SCM
AGN

Segantii Capital Management’s Allergan plc AGN Stock Holding History

Segantii Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-331,439
Closed -$58.7M – 104
2020
Q1 		$58.7M Sell
331,439
-680,109
-67% -$128M 4.68% 7
2019
Q4 		$193M Buy
+1,011,548
New +$182M 14.06% 1

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Segantii Capital Management's AGN Position: Q2 2020 in Review

Segantii Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 331,439 shares — an estimated $58.7M sold.

Segantii Capital Management first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $193M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Segantii Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Segantii Capital Management sold 331,439 Allergan plc shares in Q2 2020, an estimated $58.7M.
  • Segantii Capital Management first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Segantii Capital Management's Allergan plc position peaked at $193M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Segantii Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.